Oncology Institute (TOIIW) FCF Margin (2021 - 2026)

Oncology Institute (TOIIW) has reported FCF Margin for 6 consecutive years, with 2.21% the latest figure, recorded in Q1 2026.

• FCF Margin for Q1 2026 came in at 2.21%, up 288.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 4.71% (up 8.0% YoY), and the FY2025 annual result was 5.53%, up 218.0% from the prior year.
• FCF Margin was 2.21% for Q1 2026 at Oncology Institute, down from 1.53% in the prior quarter.
• Over five years, FCF Margin peaked at 2.24% in Q4 2024 and troughed at 33.23% in Q3 2022.
• Average FCF Margin over 5 years is 12.23%, with a median of 11.26% recorded in 2023.
• The widest YoY moves for FCF Margin: up 3163 bps in 2022, down 3228 bps in 2022.
• Over 5 years, FCF Margin stood at 14.65% in 2022, then surged by 62 bps to 5.54% in 2023, then jumped by 140 bps to 2.24% in 2024, then tumbled by 32 bps to 1.53% in 2025, then sank by 244 bps to 2.21% in 2026.
• Per Business Quant data, the three most recent FCF Margin figures were 2.21% in Q1 2026, 1.53% in Q4 2025, and 9.69% in Q3 2025.